SUPRES 150 TAB
SUPRES 150 TAB
Discontinued
DIN Number
00231169
Drug Class
Human
Market Date
Dec 31, 1972
Company
HC
merck frosst canada & cie, merck frosst canada & co.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number00231169
AIG Number0200051002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C02LB01 METHYLDOPA (LEVOROTATORY) AND DIURETICS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification40:28.20
Health Canada Classification
ACTIVE INGREDIENTS (2)
CHLOROTHIAZIDEActive
Strength: 150 MG
Monograph: CHLOROTHIAZIDE
METHYLDOPAActive
Strength: 250 MG
Monograph: METHYLDOPA